|
Oral formulation for novel inhibitor of Ras driven cancers
|
3R43CA217502-01A1S1
|
$2,000
|
$680
|
CANZONERI, JOSHUA
|
ADT PHARMACEUTICALS, LLC
|
|
A Major Nutritional Effect on Intestinal Stem Cells and Tumors
|
1R01CA214625-01A1
|
$294,022
|
$294,022
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
$635,306
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells
|
1R01CA229216-01
|
$493,238
|
$493,238
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-06
|
$660,173
|
$660,173
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Designing Novel Anti-Cancer Therapeutics: Targeting Methionine Metabolism
|
5F30CA210372-02
|
$49,524
|
$49,524
|
FIRESTONE, ROSS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
|
5R01CA178394-05
|
$346,525
|
$173,263
|
GAVATHIOTIS, EVRIPIDIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
$729,228
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer
|
1R01CA222469-01
|
$549,306
|
$549,306
|
MANI, SRIDHAR
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-06
|
$346,525
|
$69,305
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S1
|
$2,000
|
$2,000
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S2
|
$126,060
|
$126,060
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
Exploiting the immune response to detect pathogen-induced cancers
|
5R01CA199948-04
|
$492,377
|
$492,377
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
3R01CA201179-03S1
|
$227,376
|
$113,688
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
5R01CA201179-03
|
$655,095
|
$327,548
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Arizona Cancer and Evolution Center (ACE)
|
1U54CA217376-01A1
|
$1,906,167
|
$1,906,167
|
MALEY, CARLO
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Role of IRF8 in Tumor Rejection and Suppression
|
5R01CA133085-09
|
$307,800
|
$307,800
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression
|
5R01CA182518-05
|
$315,400
|
$315,400
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-03
|
$1,063,923
|
$361,734
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
The Effects of High Fructose Corn Syrup on Intestinal Tumorigenesis
|
1K22CA216036-01
|
$179,877
|
$179,877
|
YUN, JIHYE
|
BAYLOR COLLEGE OF MEDICINE
|
|
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
|
5U24CA210954-03
|
$973,045
|
$321,105
|
ZHANG, BING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-22
|
$372,400
|
$372,400
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER
|
5R01CA181572-05
|
$319,735
|
$319,735
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer
|
5R01CA184792-04
|
$347,517
|
$347,517
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer
|
5R01CA202797-03
|
$349,694
|
$349,694
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
5U01CA187956-05
|
$510,193
|
$510,193
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-03
|
$470,573
|
$155,289
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Tissue-specific genetic interactions in cancer
|
1R01CA232372-01
|
$505,643
|
$505,643
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Basic and Translational studies of Ras-mutant colorectal cancer
|
5R01CA178017-05
|
$359,556
|
$359,556
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Modeling KRAS genetic heterogeneity in mouse models
|
5R01CA195744-03
|
$635,205
|
$635,205
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-04
|
$1,041,188
|
$520,594
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of c-Cbl in Colon cancer
|
5R01CA175382-05
|
$361,050
|
$361,050
|
CHITALIA, VIPUL
|
BOSTON MEDICAL CENTER
|
|
Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications
|
1R01CA224911-01A1
|
$715,647
|
$715,647
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
$497,934
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
$626,379
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S1
|
$3,249,644
|
$162,482
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
$50,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
$403,689
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-10
|
$3,474,603
|
$1,181,365
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Lifestyle, genetics and colonoscopy for colorectal cancer prevention
|
5K07CA190673-06
|
$110,893
|
$110,893
|
NISHIHARA, REIKO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-19
|
$2,402,014
|
$888,745
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathways
|
5K07CA188126-04
|
$144,000
|
$144,000
|
ZHANG, XUEHONG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-03
|
$518,165
|
$259,083
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
Systematic identification of oncogenic KRAS synthetic lethal interactions
|
5U01CA199253-04
|
$807,776
|
$274,644
|
HAHN, WILLIAM
|
BROAD INSTITUTE, INC.
|
|
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
|
3R44CA176937-03S1
|
$210,000
|
$210,000
|
LING, XIANG
|
CANGET BIOTEKPHARMA, LLC
|
|
Novel Molecular Biomarkers and Therapeutics for Colorectal Cancer
|
1R50CA211119-01A1
|
$154,101
|
$154,101
|
FINK, STEPHEN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
$902,073
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-28S1
|
$249,965
|
$39,994
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
$7,680
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
EPHA6 as a novel candidate driver gene in colon cancer
|
5R01CA204549-03
|
$362,569
|
$362,569
|
GUDA, KISHORE
|
CASE WESTERN RESERVE UNIVERSITY
|
Total relevant funding to Colon/Rectum for this search: $256,014,245
|